FrancophonIA/ELRC3.0 huggingface dataset:
English: The most commonly reported potentially life-threatening or fatal adverse events include mucositis, diarrhoea, neutropaenia, renal impairment, and electrolyte disturbance.
Slovenian: Najpogosteje poročani neželeni učinki, ki so lahko smrtno nevarni ali smrtni, so npr. mukozitis, driska, nevtropenija, ledvična okvara ter motnje elektrolitskega ravnovesja.
English: The abnormalities were controlled by conventional therapy for thyroid dysfunction.
Slovenian: Te so nadzorovali s konvencionalno terapijo za motnje delovanja ščitnice.
English: The following instructions explain how to inject IntronA yourself.
Slovenian: V spodnjih navodilih je opisano, kako si lahko sami injicirate zdravilo IntronA.
English: A wide variety of autoimmune and immune-mediated disorders have been reported with alpha interferons including thyroid disorders, systemic lupus erythematosus, rheumatoid arthritis (new or aggravated), idiopathic and thrombotic thrombocytopenic purpura, vasculitis, neuropathies including mononeuropathies (see also section 4.4).
Slovenian: Pri uporabi alfa interferonov so poročali o širokem razponu avtoimunih bolezni in bolezni imunskega sistema, npr. motnjah delovanja žleze ščitnice, sistemskem eritematoznem lupusu, revmatoidnem artritisu (novonastalem ali poslabšanem), idiopatski in trombotični trombocitopenični purpuri, vaskulitisu ter nevropatijah, vključno z mononevropatijami (glejte tudi poglavje 4.4).
English: Any patient developing pyrexia, cough, dyspnea or other respiratory symptoms must have a chest X-ray taken.
Slovenian: Pri vseh bolnikih, pri katerih se pojavijo zvišana telesna temperatura, kašelj, dispneja ali kakšni drugi respiratorni simptomi, morate opraviti rentgensko slikanje prsnega koša.
English: Change your injection site each time.
Slovenian: Pri vsakem injiciranju zamenjajte mesto injiciranja.
English: The appropriate dose of IntronA is withdrawn from the vial(s), added to 50 mL of 9 mg/mL (0.9 %) sodium chloride solution for injection in a PVC bag or glass bottle for intravenous use and administered over 20 minutes.
Slovenian: Ustrezni odmerek zdravila IntronA posesajte iz viale (vial), ga dodajte v 50 ml natrijevega klorida 9 mg/ml (0,9 %) raztopine za injekcije v PVC vrečki ali v steklenici za intravensko uporabo ter ga infundirajte bolniku v teku 20 minut.
English: 25 million IU/2.5 mL
Slovenian: 25 milijonov i.e./2,5 ml
English: Multiple-dose pharmacokinetic properties for IntronA injection and ribavirin capsules in children and adolescents with chronic hepatitis C, between 5 and 16 years of age, are summarized in Table 7.
Slovenian: Farmakokinetične lastnosti pri večkratnem odmerjanju zdravila IntronA injekcije in kapsul ribavirina pri otrocih in mladostnikih s kroničnim hepatitisom C v starosti od 5 do 16 let so povzete v Preglednici 7.
English: Be sure to discuss this with your doctor.
Slovenian: O tem se morate pogovoriti z zdravnikom.
English: Remove the syringe from the wrapping.
Slovenian: Brizgo vzemite iz ovoja.
English: Inject the solution by pushing the plunger all the way down gently (Diagram C).
Slovenian: Raztopino injicirajte tako, da bat nežno potisnete do konca (slika C).
English: Subcutaneous or intravenous use.
Slovenian: subkutana ali intravenska uporaba Razredčite pred intravensko uporabo.
English: Based on the results of clinical trials, in which data are available for 6 months of treatment, it is recommended that patients be treated with IntronA in combination with ribavirin for 6 months.
Slovenian: Na podlagi rezultatov kliničnih raziskav, v katerih so bili na voljo podatki za 6-mesečno zdravljenje, priporočamo, da bolnike z zdravilom IntronA v kombinaciji z ribavirinom zdravite 6 mesecev.
English: Dispose of the syringe with attached needle safely in a closed container.
Slovenian: Brizgo s pritrjeno iglo zavrzite varno, v zaprti posodi.
English: Activate Safety Mechanism of the syringe after removal from the injection site by moving the pushrod completely forward until the pushrod is fully extended and the needle tip is covered (Diagram D).
Slovenian: Po odstranitvi z mesta injiciranja aktivirajte varnostni mehanizem brizge tako, da potisnete pripomoček za zaščito igle naprej, dokler popolnoma ne prekrije igle (slika D).
English: The recommended dose is in the range 5 to 10 million IU administered subcutaneously three times a week (every other day) for a period of 4 to 6 months.
Slovenian: Priporočeni odmerek je v razponu od 5 do 10 milijonov i.e., injiciran subkutano trikrat na teden (vsak drugi dan) v obdobju 4 do 6 mesecev.
English: HOW TO SELF INJECT INTRONA Syringe with an attached needle and a needle protection device
Slovenian: KAKO SI LAHKO SAMI INJICIRATE ZDRAVILO INTRONA Brizga s pritrjeno iglo in pripomočkom za zaščito igle
English: The use of interferon alfa-2b in children and adolescents with existence of or history of severe psychiatric conditions is contraindicated (see section “Do not use IntronA”).
Slovenian: Uporaba interferona alfa-2b je kontraindicirana pri otrocih in mladostnikih, ki imajo oziroma so imeli v preteklosti hude psihiatrične motnje (glejte poglavje “Ne uporabljajte zdravila IntronA”).
English: Very rarely, seizures have occurred with high doses of IntronA.
Slovenian: Zelo redko so pri uporabi velikih odmerkov zdravila IntronA nastopili napadi krčev.
English: Hairy cell leukaemia The recommended dose is 2 million IU/m2 administered subcutaneously three times a week (every other day) for both splenectomised and non-splenectomised patients.
Slovenian: Dlakastocelična levkemija Priporočeni odmerek je 2 milijona i.e./m2, injicirano subkutano trikrat na teden (vsak drugi dan), tako za splenektomirane kot za nesplenektomirane bolnike.
English: 2 multiple dose vials
Slovenian: 2 viali z večkratnimi odmerki
English: Overall, in both studies, patients who received IntronA plus ribavirin, were less likely to respond than patients who received pegylated interferon alfa-2b with ribavirin.
Slovenian: Na splošno so v obeh študijah opazili, da je bila pri bolnikih, ki so prejemali zdravilo IntronA z ribavirinom, manjša verjetnost za odziv kot pri tistih, ki so prejemali pegiliran interferon alfa-2b z ribavirinom.
English: Your other hand will be free to move the plunger.
Slovenian: Z drugo roko boste premikali bat brizge.
English: Your doctor may recommend that you take paracetamol if you develop these symptoms.
Slovenian: Če se pojavijo ti simptomi, vam bo zdravnik lahko priporočil jemanje paracetamola.
English: Infrequently, adult patients treated for chronic hepatitis C with IntronA developed thyroid abnormalities, either hypothyroidism or hyperthyroidism.
Slovenian: V redkih primerih so se pri odraslih bolnikih, zdravljenih z zdravilom IntronA zaradi kroničnega hepatitisa C, pojavile bolezni ščitnice, bodisi hipotiroza ali hipertiroza.
English: The mean serum interferon concentrations following subcutaneous and intramuscular injections were comparable.
Slovenian: Srednja serumska koncentracija interferona po subkutanem injiciranju je bila podobna tisti po intramuskularnem injiciranju.
English: Table 2 Adverse reactions very commonly and commonly reported during clinical trials in children and adolescent patients treated with IntronA in combination with ribavirin
Slovenian: Preglednica 2 Neželeni učinki, o katerih so zelo pogosto in pogosto poročali v kliničnih preskušanjih pri otrocih in mladostnikih, zdravljenih s kombinacijo zdravila IntronA in ribavirina
English: Uncommonly reported side effects: bacterial infection, feeling of pins and needles, and pericarditis (inflammation of the lining of the heart).
Slovenian: Občasno poročani neželeni učinki: bakterijska okužba, mravljinčenje in perikarditis (vnetje srčne ovojnice).
English: Immune system disorders Very rarely:
Slovenian: Bolezni imunskega sistema Zelo redki:
English: IntronA 25 MIU
Slovenian: IntronA 25 mio i.e.
English: Vial label
Slovenian: Nalepka viala
English: IntronA is used in combination with ribavirin in children 3 years of age and older and adolescents who have previously untreated chronic hepatitis C.
Slovenian: Zdravilo IntronA se uporablja v kombinaciji z ribavirinom pri otrocih, starih 3 leta ali več, in mladostnikih, ki imajo predhodno nezdravljeni kronični hepatitis C.
English: - The active substance is recombinant interferon alfa-2b.
Slovenian: - Učinkovina je rekombinantni interferon alfa-2b.
English: Pull back on the plunger slowly to draw the correct dose as prescribed by your doctor into the syringe.
Slovenian: Počasi povlecite bat nazaj, da v brizgo izvlečete ustrezen odmerek zdravila, kot ga je predpisal zdravnik.
English: Adjunctively with chemotherapy, interferon alfa-2b may be administered subcutaneously, at a dose of 5 million IU three times a week (every other day) for a duration of 18 months.
Slovenian: Dodatno h kemoterapiji lahko bolniku subkutano dajete še interferon alfa-2b v odmerku 5 milijonov i.e. trikrat na teden (vsak drugi dan) 18 mesecev.
English: Chronic hepatitis C: Adults - 3 million IU 3 times a week (every other day) injected subcutaneously (under the skin) in combination with ribavirin or alone.
Slovenian: Kronični hepatitis C: Odrasli - 3 milijoni i.e. 3 krat na teden (vsak drugi dan) s subkutano (podkožno) injekcijo v kombinaciji z ribavirinom ali sam.
English: IntronA is given in combination with ribavirin.
Slovenian: IntronA se uporablja v kombinaciji z ribavirinom.
English: While being treated with IntronA, your doctor may want you to drink extra fluids to help prevent low blood pressure.
Slovenian: Zdravilo IntronA skupaj s hrano, pijačo in alkoholom Medtem, ko prejemate zdravilo IntronA, vam bo zdravnik lahko naročil, da pijte več tekočine, da bi preprečili nizek krvni tlak.
English: In clinical trials using IntronA therapy, 2.8 % patients overall developed thyroid abnormalities.
Slovenian: V kliničnih raziskavah terapije z zdravilom IntronA so se pri 2,8 % vseh bolnikov pojavile bolezni ščitnice.
English: IntronA may be administered using either glass or plastic disposable injection syringes.
Slovenian: Zdravilo IntronA lahko injicirate s steklenimi ali plastičnimi brizgami za enkratno uporabo.
English: If ALT flares during IntronA therapy to greater than or equal to 2 times baseline, IntronA therapy may be continued unless signs and symptoms of liver failure are observed.
Slovenian: Tudi če se med terapijo z zdravilom IntronA naglo povečajo vrednosti ALT na 2-kratno začetno vrednost ali celo več, lahko terapijo z zdravilom IntronA nadaljujete, razen če opažate simptome in znake jetrne odpovedi.
English: Multiple myeloma
Slovenian: Multipli mielom
English: When the white blood cell count is controlled, administer the maximum tolerated dose of IntronA (4 to 5 million IU/m daily) to maintain haematological remission.
Slovenian: Ko je število levkocitov pod nadzorom, dajte bolniku največji odmerek zdravila IntronA, ki ga še prenaša (4 do 5 milijonov i.e./m na dan), za ohranjanje hematološke remisije.
English: Remove the needle guard.
Slovenian: Z igle snemite zaščitni pokrovček.
English: At the discretion of the physician, the patient may self-administer the dose for maintenance dose regimens administered subcutaneously.
Slovenian: Zdravnik lahko po lastni presoji bolniku dovoli, da si sam subkutano injicira vzdrževalni odmerek zdravila.
English: Carcinoid tumour
Slovenian: Karcinoidni tumorji
English: Additionally, Vogt-Koyanagi-Harada syndrome (an autoimmune inflammatory disorder affecting the eyes, skin and the membranes of the ears, brain and spinal cord), thoughts about threatening the life of others, mania (excessive or unreasonable enthusiasm), bipolar disorders (mood disorders characterized by alternating episodes of sadness and excitement), congestive heart failure, pericardial effusion (a fluid collection that develops between the pericardium (the lining of the heart) and the heart itself), pulmonary fibrosis (scarring of the lungs), and hepatitis B reactivation in HCV/HBV co-infected patients (recurrence of hepatitis B disease) have been reported with IntronA use.
Slovenian: Poleg tega so pri uporabi zdravila IntronA poročali tudi o pojavu sindroma Vogt-Koyanagi-Harada (avtoimuna vnetna bolezen, ki prizadene oči, kožo in ušesne membrane ter možganske ovojnice in ovojnice hrbtenjače), o pojavu misli, kako ogroziti življenje drugih, maniji (čezmerno ali nesmiselno navdušenje), bipolarnih motnjah (motnje razpoloženja, za katere je značilno izmenjevanje obdobij žalostnega razpoloženja z obdobji navdušenosti), kongestivnem srčnem popuščanju, perikardnem izlivu (nabiranje tekočine med perikardom (srčno ovojnico) in samim srcem), pljučni fibrozi (brazgotinjenje pljuč) in reaktivaciji hepatitisa B pri bolnikih, sočasno okuženih s HCV/HBV (ponovni pojav bolezni hepatitisa B).
English: No other medicinal product can be infused concomitantly with IntronA.
Slovenian: Sočasno z zdravilom IntronA ne smete infundirati nobenih drugih zdravil.
English: All Genotype 1,
Slovenian: Genotipa 1,
English: Prior to initiation of IntronA therapy, TSH levels must be evaluated and any thyroid abnormality detected at that time must be treated with conventional therapy.
Slovenian: Pred uvedbo zdravljenja z zdravilom IntronA je treba oceniti vrednosti TSH, morebitne motnje delovanja žleze ščitnice, ki jih pri tem ugotovite, pa je treba zdraviti z običajno terapijo.
English: Children 3 years of age or older and adolescents IntronA 3 MIU/m2 is administered subcutaneously 3 times a week (every other day) in combination with ribavirin capsules or oral solution administered orally in two divided doses daily with food (morning and evening).
Slovenian: Otroci, stari 3 leta ali starejši, in mladostniki Zdravilo IntronA 3 milijone i.e. /m se uporablja subkutano trikrat na teden (vsak drugi dan) v kombinaciji s kapsulami ali peroralno raztopino ribavirina peroralno v dveh deljenih odmerkih s hrano (zjutraj in zvečer).
English: Some patients have been shown to benefit from IntronA 5 million IU/m administered daily subcutaneously in association with cytarabine (Ara-C) 20 mg/m2 administered daily subcutaneously for 10 days per month (up to a maximum daily dose of 40 mg).
Slovenian: Pri nekaterih bolnikih se je kot koristna izkazala uporaba zdravila IntronA 5 milijonov i.e./m dnevno subkutano v kombinaciji s citarabinom (Ara-C) 20 mg/m2 dnevno subkutano 10 dni na mesec (do največjega dnevnega odmerka 40 mg).
English: Preclinical juvenile toxicity results have demonstrated a minor, dose-related decrease in overall growth in neonatal rats dosed with ribavirin (see section 5.3 of Rebetol SPC if IntronA is to be administered in combination with ribavirin).
Slovenian: Predklinične študije juvenilne toksičnosti kažejo majhno, od odmerka odvisno zmanjšanje rasti glede na odmerek ribavirina pri podganah (če boste zdravilo IntronA uporabljali v kombinaciji z ribavirinom, glejte poglavje 5.3 v SPC-ju za zdravilo Rebetol).
English: Fungal infection, bacterial infection, pulmonary infection, otitis media, tooth abscess, herpes simplex, urinary tract infection, vaginitis, gastroenteritis
Slovenian: virusna okužba, faringitis glivna okužba, bakterijska okužba, okužba pljuč, vnetje srednjega ušesa, zobni absces, herpes simpleks, okužba sečil, vaginitis, gastroenteritis
English: If you are receiving HAART, the addition of IntronA and ribavirin may increase your risk of lactic acidosis and of liver failure.
Slovenian: Če prejemate HAART, lahko dodatek zdravila IntronA in ribavirina tej terapiji poveča tveganje za nastanek laktoacidoze in jetrne odpovedi.
English: Current treatment guidelines should be consulted as to whether a liver biopsy is needed prior to commencing treatment.
Slovenian: Pri odločanju, ali je pred začetkom zdravljenja potrebna biopsija jeter, upoštevajte tekoče smernice za zdravljenje.
English: Patients treated with IntronA and ribavirin combination therapy and zidovudine could be at increased risk of developing anaemia.
Slovenian: Pri bolnikih, zdravljenih s kombinacijo zdravila IntronA in ribavirina ter zidovudinom, se lahko poveča tveganje za pojav anemije.
English: In patients treated for malignant melanoma, liver function and white blood cell (WBC) count and differential must be monitored weekly during the induction phase of therapy and monthly during the maintenance phase of therapy.
Slovenian: Pri bolnikih, ki se zdravijo zaradi malignega melanoma, morate spremljati delovanje jeter in število levkocitov ter diferencialno krvno sliko, in sicer enkrat na teden v uvajalni fazi zdravljenja , med vzdrževalno fazo zdravljenja pa enkrat na mesec.
English: The efficacy of IntronA is enhanced when given in combination with ribavirin.
Slovenian: Učinkovitost zdravila IntronA je večja, če ga uporabljate v kombinaciji z ribavirinom.
English: 1 mL and 144 cleansing swabs
Slovenian: 144 čistilnih tamponov
English: As maintenance treatment, the recommended dose is 10 million IU/m2 administered subcutaneously three days a week (every other day) for 48 weeks.
Slovenian: Za vzdrževalno zdravljenje je priporočeni odmerek 10 milijonov i.e./m2, subkutano, 3 dni na teden (vsak drugi dan), 48 tednov.
English: Pulmonary conditions
Slovenian: Pljučne bolezni
English: The Kaplan-Meier estimate for continued sustained response over 5 years is 98 % [95 % CI: 95 %, 100 %] for paediatric patients treated with interferon alfa-2b and ribavirin.
Slovenian: Kaplan-Meierjeva ocena ohranitve trajnega virološkega odziva v obdobju 5 let pri pediatričnih bolnikih, zdravljenih z interferonom alfa-2b in ribavirinom, znaša 98 % [95 % IZ: 95 %, 100 %].
English: Hypocalcaemia, dehydration, hyperuricemia, thirst Hyperglycaemia, hypertriglyceridaemia
Slovenian: anoreksija hipokalciemija, dehidracija, hiperurikemija, žeja hiperglikemija, hipertrigliceridemija
English: Hypertriglyceridemia
Slovenian: Hipertrigliceridemija
English: SVR after treatment of chronic HCV with non-pegylated interferon alfa-2b with ribavirin results in long-term clearance of the virus providing resolution of the hepatic infection and clinical 'cure' from chronic HCV.
Slovenian: SVR po zdravljenju kronične okužbe s HCV z nepegiliranim interferonom alfa-2b in ribavirinom vodi do dolgoročnega očistka virusa, s čimer zagotovimo odpravo jetrne okužbe in klinično 'ozdravitev' kronične okužbe s HCV.
English: What IntronA contains
Slovenian: Kaj vsebuje zdravilo IntronA
English: The usual dose is 5 million IU (3 to 9 million IU) administered subcutaneously three times a week (every other day).
Slovenian: Običajni odmerek je 5 milijonov i.e. (3 do 9 milijonov i.e.), dan subkutano trikrat na teden (vsak drugi dan).
English: These symptoms have been reported more frequently when shosaikoto, a Chinese herbal medicine, is administered concomitantly with interferon alpha (see section 4.4).
Slovenian: O teh simptomih so poročali pogosteje pri sočasni uporabi kitajskega zeliščnega pripravka shosaikoto in interferona alfa (glejte poglavje 4.4).
English: Patients who received IntronA plus ribavirin were less likely to respond than patients who received pegylated interferon alfa-2b and ribavirin.
Slovenian: Pri bolnikih, ki so prejeli zdravilo IntronA z ribavirinom, je bila manjša verjetnost odziva kot pri tistih, ki so prejeli pegilirani interferon alfa-2b in ribavirin.
English: Hypertriglyceridemia and aggravation of hypertriglyceridemia, sometimes severe, have been observed.
Slovenian: Opazili so hipertrigliceridemijo in poslabšanje hipertrigliceridemije, ki je bilo včasih hudo, zato priporočamo spremljanje lipidov v krvi.
English: Periodontal (affecting gums) and dental disorders, change in colour of the tongue, altered mental status, loss of consciousness, acute hypersensitivity reactions including urticaria (hives), angioedema (swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty in swallowing or breathing), bronchoconstriction and anaphylaxis (a severe, whole-body allergic reaction) have been reported, but their frequency is unknown.
Slovenian: Poročali so tudi o paradontalni bolezni (prizadetost dlesni), zobnih boleznih, spremembi barve jezika, spremenjenem duševnem stanju, izgubi zavesti ter akutnih preobčutljivostnih reakcijah, vključno z urtikarijo (koprivnico), angioedemom (otekanjem dlani, stopal, gležnjev, obraza, ustnic, ust ali žrela, ki lahko povzroči težave pri požiranju ali dihanju), bronhokonstrikcijo in anafilaksijo (huda alergijska reakcija po vsem telesu), vendar njihova pogostnost ni znana.
English: Extreme care must be taken to avoid pregnancy in female patients or in partners of male patients taking IntronA in combination with ribavirin.
Slovenian: Ribavirin lahko povzroči hude poškodbe ploda, če se uporablja med nosečnostjo, zato je potrebna skrajna previdnost v izogib nosečnosti pri bolnicah ali pri partnerkah bolnikov, ki jemljejo zdravilo IntronA v kombinaciji z ribavirinom.
English: Concomitant chemotherapy
Slovenian: Sočasna kemoterapija
English: If thyroid abnormalities are detected, the patient's thyroid status should be evaluated and treated as clinically appropriate.
Slovenian: Če ugotovite motnje delovanja ščitnice, je treba pri bolniku oceniti stanje žleze ščitnice in ga zdraviti glede na klinično stanje.
English: Myocardial infarction, cardiac ischaemia Congestive heart failure, pericardial effusion, arrhythmia
Slovenian: palpitacije, tahikardija perikarditis kardiomiopatija miokardni infarkt, ishemija srca kongestivno srčno popuščanje, perikardni izliv, aritmija
English: IntronA was administered at a dose of 3 MIU 3 times a week as monotherapy or in combination with ribavirin.
Slovenian: Zdravilo IntronA so dajali bolnikom v odmerku 3 mio i.e. trikrat na teden, v monoterapiji ali v kombinaciji z ribavirinom.
English: Maintenance therapy
Slovenian: Vzdrževalna terapija
English: HCV/HIV Coinfection
Slovenian: Sočasna okužba s HCV/HIV
English: Check with your doctor immediately if you have any of these symptoms.
Slovenian: Če imate katerega od teh simptomov, se nemudoma posvetujte z zdravnikom.
English: Inject the solution by pushing the plunger all the way down gently.
Slovenian: Raztopino injicirajte tako, da bat nežno potisnete do konca.
English: No studies have been conducted in juvenile animals to examine the effects of treatment with interferon alfa-2b on growth, development, sexual maturation, and behaviour.
Slovenian: Študije za proučevanje učinkov zdravljenja z interferonom alfa-2b na rast, razvoj, spolno zorenje in vedenje živali niso bile opravljene pri mladih živalih.
English: Hyperkinesia, tremor, dysphonia, paresthaesia, hypoaesthesia, hyperaesthesia, concentration impaired, somnolence
Slovenian: glavobol, omotica hiperkinezija, tremor, disfonija, parestezije, hipoestezija, hiperestezija, motnje koncentracije, zaspanost
English: Co-infected patients with advanced cirrhosis receiving HAART may be at increased risk of hepatic decompensation and death.
Slovenian: Pri bolnikih, ki so sočasno okuženi z virusom HIV in imajo napredovano cirozo ter prejemajo terapijo HAART, je lahko povečano tveganje za jetrno dekompenzacijo in smrt.
English: While pyrexia may be associated with the flu-like syndrome reported commonly during interferon therapy, other causes of persistent pyrexia must be ruled out.
Slovenian: Četudi je zvišana telesna temperatura lahko povezana z gripoznim sindromom, ki je pogost med zdravljenjem z interferonom, morate najprej izključiti druge vzroke za trdovratno zvišano telesno temperaturo.
English: Headache, dizziness
Slovenian: zardevanje, bledica
English: HOW TO SELF INJECT INTRONA Syringe with an unattached needle
Slovenian: KAKO SI LAHKO SAMI INJICIRATE ZDRAVILO INTRONA Brizga z nepritrjeno iglo
English: See section 4.4 Class label for interferon products, see below Pulmonary arterial hypertension.
Slovenian: Velja za skupino zdravil, ki vsebujejo interferone - glejte Pljučna arterijska hipertenzija spodaj.
English: The administered dose should be reduced by 50 % in case of occurrence of haematological disorders (white blood cells < 1,500/mm 3, granulocytes < 1,000/mm 3, thrombocytes < 100,000/mm 3).
Slovenian: Če se pojavijo hematološke motnje (število levkocitov < 1.500/mm 3, število granulocitov < 1.000/mm število trombocitov < 100.000/mm 3), odmerek zmanjšajte za 50 %.